Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT01738646
What this trial is testing

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Who this might be right for
Recurrent Glioblastoma MultiformeMalignant GliomaAdult Brain Tumor
Duke University 48
Not applicableLooking for participantsNCT06788886
What this trial is testing

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Who this might be right for
Malignant Brain NeoplasmMalignant Solid NeoplasmMultiple Sclerosis+2 more
Mayo Clinic 147
Testing effectiveness (Phase 2)Study completedNCT04817254
What this trial is testing

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcomaMalignant Glioma
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Not applicableStudy completedNCT04132843
What this trial is testing

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

Who this might be right for
Brain NeoplasmLymphomaMetastatic Malignant Neoplasm in the Brain+1 more
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT02953717
What this trial is testing

Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)

Who this might be right for
Neoplasm Metastasis
Elisabeth-TweeSteden Ziekenhuis 81
Not applicableUnknownNCT00349024
What this trial is testing

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChordomaKidney Cancer+7 more
Children's Cancer and Leukaemia Group 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03741673
What this trial is testing

Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 180
Not applicableUnknownNCT05981170
What this trial is testing

Rurality Adapted Physical Activity Sport Health

Who this might be right for
Brain TumourMetastatic Cancer
Institut Cancerologie de l'Ouest 10
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableStudy completedNCT02162732
What this trial is testing

Molecular-Guided Therapy for Childhood Cancer

Who this might be right for
NeuroblastomaMedulloblastomaGlioma+16 more
Giselle Sholler 186
Not applicableStudy completedNCT03323580
What this trial is testing

Effects of Intraoperative GDFT on the Postoperative Brain Edema

Who this might be right for
Fluid TherapyBrain EdemaBrain Tumor
Beijing Tiantan Hospital 480
Large-scale testing (Phase 3)Ended earlyNCT00002899
What this trial is testing

Adjuvant Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 340
Not applicableStudy completedNCT02150564
What this trial is testing

3D Ultra Sound for Resection of Brain Tumors

Who this might be right for
Patients With Resectable Brain Tumors
Tata Memorial Hospital 72
Testing effectiveness (Phase 2)Study completedNCT01253564
What this trial is testing

RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 24
Large-scale testing (Phase 3)Study completedNCT00054795
What this trial is testing

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Who this might be right for
Brain NeoplasmsCarcinoma, Non-Small-Cell LungMetastases, Neoplasm
Pharmacyclics LLC. 550
Early research (Phase 1)Study completedNCT00020150
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT05832450
What this trial is testing

Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR)

Who this might be right for
Brain Tumor AdultTransfusionSurgery
Clinica Universidad de Navarra, Universidad de Navarra 1,434
Testing effectiveness (Phase 2)Ended earlyNCT01868906
What this trial is testing

FMISO-PET in Brain Tumors and SCS Effect

Who this might be right for
Malignant Glioma
Bernardino Clavo, MD, PhD 6
Next Page